Trove
Sign In Sign Up

Truveris, Inc.

Organization
Mentions
6
Relationships
1
Events
0
Documents
3
Also known as:
Truveris
Search

Relationship Network

Loading... nodes
Interactive Network: Click nodes or edges to highlight connections and view details with action buttons. Drag nodes to reposition. Node size indicates connection count. Line color shows relationship strength: red (8-10), orange (6-7), yellow (4-5), gray (weak). Use legend and help buttons in the graph for more guidance.
1 total relationships
Connected Entity Relationship Type
Strength (mentions)
Documents Actions
person New Leaf Ventures (NLV)
Financial
5
1
View
No events found for this entity.

HOUSE_OVERSIGHT_024051.jpg

This document is a page from a confidential investment memorandum (Control Number 257) produced for the House Oversight Committee. It details the investment strategy for 'NLV-III' (New Leaf Ventures III), focusing on healthcare themes like patient engagement and cost transparency, citing past successes with companies like Audax Health and Truveris. The text outlines the fund's strategy to invest in U.S. private companies, take significant ownership positions, and leverage board participation.

Investment memorandum / fund strategy report
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024022.jpg

This document is page 11 of a confidential presentation (likely an investment prospectus for 'NLV-III') detailing the history and senior team of New Leaf Ventures. It features a timeline of funds raised from 1993 to 2007 under Sprout and New Leaf brands, totaling billions in capital. The page highlights the biography of Managing Director Philippe Chambon, detailing his history with Sprout, Boston Consulting Group, and Sandoz Pharmaceutical, as well as his numerous board memberships in the healthcare and biotech sectors. The document bears a House Oversight Committee control number.

Investment prospectus / private placement memorandum
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024100.jpg

This document is a confidential financial appendix (Appendix 1) labeled 'Listing of Investments by Fund' for New Leaf Ventures II, L.P., dated March 31, 2014. It details the financial performance of numerous healthcare, therapeutic, and diagnostic companies in the fund's portfolio, split into realized/partially realized and unrealized investments. The document bears a House Oversight Committee stamp and a confidential control number, indicating it is part of a congressional investigation.

Financial report / investment schedule
2025-11-19
Analysis Source
Total Received
$0.00
0 transactions
Total Paid
$0.00
0 transactions
Net Flow
$0.00
0 total transactions
No financial transactions found for this entity. Entity linking may need to be improved.
As Sender
0
As Recipient
0
Total
0
No communications found for this entity. Entity linking may need to be improved.

Discussion 0

Sign in to join the discussion

No comments yet

Be the first to share your thoughts on this epstein entity

Back to Search